Low expression of POLβ nuclear protein in DCIS was an independent predictor of a poor outcome in DCIS when plotted against patient age, DCIS size, nuclear grade, radio-therapeutic treatment, HER2 status and proliferation index Ki67 (p = 0.031. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.